State Street Corp Bio Rad Laboratories, Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, State Street Corp holds 635,916 shares of BIO stock, worth $218 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
635,916
Previous 859,891 26.05%
Holding current value
$218 Million
Previous $235 Million 9.4%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$263.97 - $344.64 $59.1 Million - $77.2 Million
-223,975 Reduced 26.05%
635,916 $213 Million
Q2 2024

Aug 14, 2024
SELL
$268.26 - $339.48 $3.7 Million - $4.68 Million
-13,784 Reduced 1.58%
859,891 $235 Million
Q1 2024

May 15, 2024
SELL
$304.11 - $351.99 $376,792 - $436,115
-1,239 Reduced 0.14%
873,675 $302 Million
Q4 2023

Feb 14, 2024
BUY
$269.37 - $365.04 $4.2 Million - $5.69 Million
15,591 Added 1.81%
874,914 $283 Million
Q3 2023

Nov 14, 2023
SELL
$350.25 - $422.63 $14.4 Million - $17.4 Million
-41,250 Reduced 4.58%
859,323 $308 Million
Q2 2023

Aug 14, 2023
SELL
$359.49 - $486.4 $7.65 Million - $10.4 Million
-21,279 Reduced 2.31%
900,573 $341 Million
Q1 2023

May 15, 2023
SELL
$418.69 - $503.0 $10.9 Million - $13 Million
-25,926 Reduced 2.74%
921,852 $442 Million
Q4 2022

Feb 14, 2023
SELL
$351.71 - $456.01 $3.84 Million - $4.98 Million
-10,926 Reduced 1.14%
947,778 $399 Million
Q3 2022

Nov 15, 2022
BUY
$412.59 - $563.26 $1.18 Million - $1.62 Million
2,869 Added 0.3%
958,704 $400 Million
Q2 2022

Aug 15, 2022
SELL
$463.67 - $597.16 $13.3 Million - $17.1 Million
-28,697 Reduced 2.91%
955,835 $473 Million
Q1 2022

May 16, 2022
SELL
$524.57 - $735.42 $12.6 Million - $17.7 Million
-24,002 Reduced 2.38%
984,532 $555 Million
Q4 2021

Feb 14, 2022
BUY
$708.84 - $794.68 $18.6 Million - $20.8 Million
26,229 Added 2.67%
1,008,534 $762 Million
Q3 2021

Nov 15, 2021
BUY
$657.71 - $825.77 $5.17 Million - $6.49 Million
7,864 Added 0.81%
982,305 $733 Million
Q2 2021

Aug 16, 2021
BUY
$576.64 - $649.04 $1.56 Million - $1.75 Million
2,702 Added 0.28%
974,441 $628 Million
Q1 2021

May 17, 2021
SELL
$547.01 - $662.35 $3.19 Million - $3.86 Million
-5,833 Reduced 0.6%
971,739 $555 Million
Q4 2020

Feb 16, 2021
BUY
$510.68 - $643.45 $9.62 Million - $12.1 Million
18,835 Added 1.96%
977,572 $570 Million
Q3 2020

Nov 10, 2020
BUY
$454.43 - $535.6 $14.4 Million - $17 Million
31,795 Added 3.43%
958,737 $494 Million
Q2 2020

Aug 14, 2020
BUY
$334.87 - $493.06 $80.5 Million - $118 Million
240,255 Added 34.99%
926,942 $419 Million
Q1 2020

May 11, 2020
BUY
$320.01 - $409.07 $220 Million - $281 Million
686,687 New
686,687 $241 Million

Others Institutions Holding BIO

# of Institutions
455
Shares Held
18.2M
Call Options Held
19.5K
Put Options Held
13.9K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.43B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email